Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Basel Medical (BMGL) Net Income towards Common Stockholders (2023 - 2024)

Historic Net Income towards Common Stockholders for Basel Medical (BMGL) over the last 2 years, with Q4 2024 value amounting to -$237753.1.

  • Basel Medical's Net Income towards Common Stockholders fell 11259.0% to -$237753.1 in Q4 2024 from the same period last year, while for Jun 2025 it was $1.7 million, marking a year-over-year change of. This contributed to the annual value of -$9.1 million for FY2025, which is 69549.1% down from last year.
  • According to the latest figures from Q4 2024, Basel Medical's Net Income towards Common Stockholders is -$237753.1, which was down 11259.0% from $1.9 million recorded in Q4 2023.
  • Over the past 5 years, Basel Medical's Net Income towards Common Stockholders peaked at $1.9 million during Q4 2023, and registered a low of -$237753.1 during Q4 2024.